The company will occupy booth No. six for recruiting purposes and present two scientific abstracts:
Atheroprone Hemodynamics and Oxidized Phospholipids Enhance Endothelial and Smooth Muscle Inflammatory Signaling
Presentation Date and Time:April 18th from 5:30pm to 7:30pm
Abstract ID Number: 580
Poster Presentation Number: 179
Presenter: Ryan Feaver, Ph.D., HemoShear, Scientific Director
The Thrombotic Potential of the Endothelium Is Regulated by Hemodynamic Flow
Presentation Date and Time:April 20th from 8:00am to 10:00am
Abstract ID Number: 588
Poster Presentation Number: 521
Presenter: Michael Simmers, Ph.D., HemoShear, Scientific Director
HemoShear team members attending the conference include Brett Blackman, Ph. D., co-founder, Chief Scientific Officer; Brian Wamhoff, Ph.D., co-founder, Vice President of Research and Development; Nicole Hastings, Ph.D., Vice President of Operations; Ryan Feaver, Ph.D., Scientific Director; Michael Simmers, Ph.D., Scientific Director.
About HemoShear, LLC
HemoShear creates human-relevant systems that accurately replicate the biology of organ systems and diseases throughout drug discovery and development. Working in strategic partnerships with pharmaceutical, biotechnology and medical device companies, HemoShear generates meaningful data to increase confidence in decision-making, reduce risk of costly failures and identify efficacious therapies. HemoShear's science leads to new medicines and improves human health.